Related Experiment Video
Updated: Aug 9, 2026

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
MeCP2 dysregulation inhibits mitophagy and impairs neural development in cortical organoids
Jing Zhou1, Yuchun Liu2, Xintao Jing3
1Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China; Central Laboratory, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi 330006, China.
Introduction:
Methylated CpG-binding protein 2 (MeCP2) plays a critical role in the normal development and function of the nervous system. Mutations in MeCP2 have been linked to neurodevelopmental disorders, potentially because of mitochondrial dysfunction and impaired mitophagy. However, the underlying mechanisms remain poorly understood. Investigating the role of MeCP2 in the regulation of mitophagy is essential for elucidating the pathogenesis of these disorders.
Objectives:
The aim of the present study was to explore the molecular mechanisms by which MeCP2 regulates mitophagy and determine how its dysfunction contributes to neurodevelopmental abnormalities using cortical organoids (COs) derived from MeCP2 mutant induced pluripotent stem cells (iPSCs).
Methods:
CRISPR-Cas9 technology was used to generate MeCP2 mutant iPSCs, which were then differentiated into cortical organoids. Growth, proliferation, and differentiation of neural stem cells in these organoids were analysed. Single-cell RNA sequencing was performed to assess the changes in gene expression, focusing on mitophagy-related genes. MeCP2 occupancy at the BNIP3L transcription start site (TSS) was also examined.
Results:
MeCP2 mutant COs exhibited growth inhibition, abnormal proliferation, and disrupted neural stem cell differentiation. Single-cell RNA sequencing revealed a significant downregulation of BNIP3L, a key mitophagy receptor. MeCP2 was found to occupy the BNIP3L TSS, leading to suppressed BNIP3L expression and impaired mitophagy in COs.
Conclusion:
The obtained findings demonstrate that MeCP2 regulates mitophagy by modulating BNIP3L expression, and its dysfunction leads to mitochondrial accumulation and neurodevelopmental abnormalities. The present study highlights the critical role of MeCP2 in maintaining mitochondrial homeostasis and provides insights into the molecular mechanisms underlying MeCP2-related neurodevelopmental disorders.
Insights
Methylated CpG-binding protein 2 (MeCP2) regulates mitophagy by controlling BNIP3L gene expression. MeCP2 mutations impair mitophagy, causing mitochondrial issues and neurodevelopmental problems.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Methylated CpG-binding protein 2 (MeCP2) is crucial for nervous system development.
- Mutations in MeCP2 are linked to neurodevelopmental disorders, potentially due to mitochondrial dysfunction and impaired mitophagy.
- The precise mechanisms linking MeCP2 dysfunction to these disorders are not fully understood.
Purpose of the Study:
- To investigate how MeCP2 regulates mitophagy.
- To explore the molecular mechanisms underlying MeCP2's role in mitophagy.
- To determine how MeCP2 dysfunction contributes to neurodevelopmental abnormalities using human cortical organoids.
Main Methods:
- Generated MeCP2 mutant induced pluripotent stem cells (iPSCs) using CRISPR-Cas9.
- Differentiated iPSCs into cortical organoids (COs).
- Analyzed neural stem cell growth, proliferation, differentiation, and gene expression via single-cell RNA sequencing, focusing on mitophagy genes and MeCP2 binding at the BNIP3L promoter.
Main Results:
- MeCP2 mutant COs showed growth inhibition, abnormal proliferation, and disrupted neural stem cell differentiation.
- Single-cell RNA sequencing identified significant downregulation of the mitophagy receptor BNIP3L in mutant COs.
- MeCP2 was found to bind to the BNIP3L transcription start site, suppressing its expression and impairing mitophagy.
Conclusions:
- MeCP2 regulates mitophagy by modulating BNIP3L expression.
- MeCP2 dysfunction leads to mitochondrial accumulation and neurodevelopmental abnormalities.
- This study elucidates MeCP2's role in mitochondrial homeostasis and provides insights into MeCP2-related neurodevelopmental disorders.
Related Concept Videos
Pleiotropy
Epigenetic Regulation
Master Transcription Regulators
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Induced Pluripotent Stem Cells
Somatic cells are...

